Blue Cross Blue Shield New York Coverage Criteria for Rezlidhia (Olutasidenib): Complete Prior Authorization and Appeals Guide
Answer Box: Getting Rezlidhia Covered by Blue Cross Blue Shield in New York
Blue Cross Blue Shield of New York requires prior authorization for Rezlidhia (olutasidenib) in adults with relapsed/refractory AML and susceptible IDH1 mutation. Your fastest path to approval: 1) Confirm IDH1 mutation via FDA-approved test, 2) Submit